Form 4: Director Lisa Piercey Receives NHC Stock Option Grant

Sentiment:

Director Equity Grant


National HealthCare Corporation director Lisa Piercey was granted 7,500 stock options as part of the company's 2020 Omnibus Equity Incentive Plan.

Summary

  • Director Lisa Piercey received a grant of 7,500 stock options for National HealthCare Corporation (NHC) common stock.
  • The options were granted on May 7, 2026, with an exercise price of $171.42 per share.
  • The options are exercisable immediately and expire on May 6, 2030.
  • The transaction was executed under the 2020 Omnibus Equity Incentive Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation, which carries a neutral sentiment.

Positives

  • Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

  • The grant results in potential future dilution of existing shareholders upon exercise.

Risks

  • Market price volatility may impact the value of the granted options.
  • The exercise price of $171.42 represents a future obligation that depends on the company's stock performance.

Future Outlook

The options are exercisable starting May 7, 2026, and remain valid until May 6, 2030, reflecting a long-term incentive structure for the director.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices in the healthcare services sector to ensure leadership remains incentivized to drive long-term operational performance.

Comparison to Industry Standards

  • The use of an Omnibus Equity Incentive Plan is consistent with standard compensation practices for publicly traded healthcare companies.
  • The four-year vesting/expiration window is typical for director-level equity compensation in the U.S. healthcare industry.

Stakeholder Impact

  • Shareholders may experience minor dilution if the options are exercised.

Next Steps

  • Director may choose to exercise options at any time between May 7, 2026, and May 6, 2030, subject to company policy.

Key Dates

DateDescription
05/07/2026Grant date of stock options and earliest transaction date.
05/06/2030Expiration date of the granted stock options.

Keywords

National HealthCare Corporation, NHC, Form 4, Stock Options, Insider Trading, Equity Incentive Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.